Galera Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates
ROMAN Phase 3 Trial Topline Data Readout Guidance Updated to 2H21 Due to Impact of COVID-19Amendment to Royalty Agreement for […]
Ruhnn to Participate in Citi Pan-Asia Regional Investor Conference
HANGZHOU, China, May 12, 2020 (GLOBE NEWSWIRE) — Ruhnn Holding Limited (“Ruhnn” or the “Company”) (NASDAQ: RUHN), a leading internet […]
Applied Therapeutics to Present at the UBS Global Healthcare Conference
NEW YORK, May 12, 2020 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline […]
Lyft Announces Private Offering of $650 million of Convertible Senior Notes and Capped Call to Increase Effective Conversion Premium to 150%
SAN FRANCISCO, May 12, 2020 (GLOBE NEWSWIRE) — Lyft, Inc. (“Lyft”) (NASDAQ: LYFT) today announced its intention to offer, subject […]
Agios to Present at the RBC Capital Markets Global Healthcare Virtual Conference on Tuesday, May 19, 2020
CAMBRIDGE, Mass., May 12, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism […]
IGM Biosciences to Present at the 2020 RBC Capital Markets Global Healthcare Conference
MOUNTAIN VIEW, Calif., May 12, 2020 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on […]
Karyopharm to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference
NEWTON, Mass., May 12, 2020 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an innovation-driven pharmaceutical company, today announced that Michael […]
Altimmune Appoints Former Pfizer and GSK Executive Diane Jorkasky, M.D. to its Board of Directors
GAITHERSBURG, Md., May 12, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment […]
VBL Therapeutics Closes $10.0 Million Registered Direct Offering and Announces $8.1 Million Registered Direct Offering to Key Current Shareholders, Each Priced At-the-Market under Nasdaq Rules
TEL AVIV, Israel, May 12, 2020 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT), today announced that it has closed the […]
Cabaletta Bio Reports First Quarter 2020 Financial Results and Provides Business Update
PHILADELPHIA, May 12, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery […]
